These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15539522)

  • 1. Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations.
    Mikolajczyk MG; Concepcion NF; Wang T; Frazier D; Golding B; Frasch CE; Scott DE
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1158-64. PubMed ID: 15539522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional antibodies to Haemophilus influenzae type B, Neisseria meningitidis, and Streptococcus pneumoniae contained in intravenous immunoglobulin products.
    Lee S; Kim HW; Kim KH
    Transfusion; 2017 Jan; 57(1):157-165. PubMed ID: 27774610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-capsular polysaccharide antibody deficiency states.
    Rijkers GT; Sanders LA; Zegers BJ
    Immunodeficiency; 1993; 5(1):1-21. PubMed ID: 8167745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations.
    Lejtenyi D; Mazer B
    J Allergy Clin Immunol; 2008 Jan; 121(1):254-5. PubMed ID: 18206511
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulatory role of intravenous gammaglobulin (IgIV) on the in vitro antibody response to a pneumococcal polysaccharide antigen.
    Leiva LE; Monjure H; Sorensen RU
    J Clin Immunol; 2015 Feb; 35(2):206-12. PubMed ID: 25504423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.
    Schauer U; Stemberg F; Rieger CH; Büttner W; Borte M; Schubert S; Möllers H; Riedel F; Herz U; Renz H; Herzog W
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):202-7. PubMed ID: 12626443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG.
    Chua I; Lagos M; Charalambous BM; Workman S; Chee R; Grimbacher B
    J Allergy Clin Immunol; 2011 Jun; 127(6):1410-1. PubMed ID: 21376379
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative measurements of Hemophilus influenzae type b capsular polysaccharide antibodies in Japanese children.
    Ishiwada N; Fukasawa C; Inami Y; Hishiki H; Takeda N; Sugita K; Kohno Y
    Pediatr Int; 2007 Dec; 49(6):864-8. PubMed ID: 18045287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature of cross-reactivity between Haemophilus influenzae types a and b and Streptococcus pneumoniae types 6A and 6B.
    Lagergård T; Branefors P
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):371-6. PubMed ID: 6201038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT.
    Parkkali T; Käyhty H; Ruutu T; Volin L; Eskola J; Ruutu P
    Bone Marrow Transplant; 1996 Nov; 18(5):961-7. PubMed ID: 8932852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.
    Huo Z; Spencer O; Miles J; Johnson J; Holliman R; Sheldon J; Riches P
    Vaccine; 2004 Mar; 22(9-10):1157-61. PubMed ID: 15003643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
    Sow SO; Tapia MD; Diallo S; Keita MM; Sylla M; Onwuchekwa U; Pasetti MF; Kotloff KL; Levine MM
    Am J Trop Med Hyg; 2009 Jun; 80(6):1033-8. PubMed ID: 19478272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of an ELISA assay for the quantification of antibodies against Haemophilus influenzae type b capsular polysaccharide].
    Toraño Peraza G; Hernández Vadell I; Baly A; Toledo Romaní ME
    Rev Cubana Med Trop; 2005; 57(3):185-91. PubMed ID: 17969271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.
    Ambrosino DM; Schiffman G; Gotschlich EC; Schur PH; Rosenberg GA; DeLange GG; van Loghem E; Siber GR
    J Clin Invest; 1985 Jun; 75(6):1935-42. PubMed ID: 3924957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions.
    Levine OS; Knoll MD; Jones A; Walker DG; Risko N; Gilani Z
    Curr Opin Infect Dis; 2010 Jun; 23(3):236-41. PubMed ID: 20407316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants.
    Breukels MA; Spanjaard L; Sanders LA; Rijkers GT
    Clin Infect Dis; 2001 Jun; 32(12):1700-5. PubMed ID: 11360210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin.
    Santosham M; Reid R; Ambrosino DM; Wolff MC; Almeido-Hill J; Priehs C; Aspery KM; Garrett S; Croll L; Foster S
    N Engl J Med; 1987 Oct; 317(15):923-9. PubMed ID: 2442610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody levels against Streptococcus pneumoniae and Haemophilus influenzae type b in a population of splenectomized individuals with varying vaccination status.
    Konradsen HB; Rasmussen C; Ejstrud P; Hansen JB
    Epidemiol Infect; 1997 Oct; 119(2):167-74. PubMed ID: 9363015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.